Jill M. Kolesar, BS Pharm, PharmD, BCPS, FCCP, is a Professor at the University of Wisconsin and the Director of the 3P Laboratory, Co-Leader Cancer Therapy Discovery and Development, Co-Chair, and Molecular Tumor Board at the University of Wisconsin Carbone Comprehensive Cancer Center. She received a BS in pharmacy from the University of Wisconsin and a PharmD from the University of Texas. Dr. Kolesar also completed an oncology residency and fellowship at the University of Texas Health Science Center in San Antonio.
Dr. Kolesar is the author of more than 125 peer reviewed publications and has received more than $1.2 million in external funding as a co and principal investigator. She holds two US and international patents for novel technologies invented in her laboratory and founded Helix Diagnostics based on this technology. She is a member of National Cancer Institute Cancer Prevention and Control Central IRB, and is currently a member of the Pharmacology Taskforce, an advisory group to the Investigational Drug Steering Committee of the NCI. She also co-chairs the Lung Biology Subcommittee for the Thoracic Committee of the Eastern Cooperative Oncology Group. Dr. Kolesar received the Innovations in Teaching Award from AACP, and has served in multiple elected offices of national and international pharmacy organizations. Other books she co-edits are Top 300 Pharmacy Flash Cards, Top 100 Nonprescription Flash Cards, and The Pharmacogenomics Handbook. Dr. Kolesar loves to read, run, ski, and travel with her husband and five children. She has completed 2 marathons and 16 half-marathons.